FDA Update on Reprocessing of Bronchoscopes

The U.S. Food and Drug Administration (FDA) has issued a safety communication regarding reprocessing of flexible bronchoscopes. According to the Agency, bronchoscopes have a high probability of remaining contaminated if the multistep process to clean and sanitize them is not properly followed.

The FDA recommends that facilities carefully follow the manufacturer’s reprocessing instructions, remove bronchoscopes that fail the leak test, or are visibly damaged, from service and  create a reprocessing quality control program.

Read the FDA announcement.

Keywords: Bronchoscopes, Bronchoscopy, Quality Control, United States Food and Drug Administration

< Back to Listings